• Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Adults with Moderate to Severe Atopic Dermatitis (Phase 2 Study)

    Not yet recruiting

    2 1
    Bulgaria Czechia Germany Italy Poland

  • A Phase III Study of ASC30 Sodium for Weight Loss in Adults with Obesity or Overweight and Type 2 Diabetes

    Not yet recruiting

    3 1
    Czechia Germany Greece Poland

  • Effect of Prucalopride Added to Sertraline Compared with Placebo on Mood and Memory in Women with Major Depressive Disorder

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Study of Tinzaparin Sodium to Prevent Venous Thromboembolism in Adults with Liver Cirrhosis and Hepatocellular Carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Long-Term Safety and Efficacy of aUroCell-Tx in Muscle-Invasive Bladder Cancer Patients Undergoing Neobladder Reconstruction – Extension Study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Greece

  • Long‑Term Follow‑Up Study of Belzupacap Sarotalocan in Patients with Early Choroidal Melanoma

    Not yet recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Italy +2

  • A Phase III Randomized Trial of Trilaciclib Dihydrochloride versus Placebo in Adults with Limited‑Stage Small Cell Lung Cancer

    Not yet recruiting

    3 1
    Belgium Czechia France Greece Spain

  • Phase 3 Study of atebimetinib with gemcitabine and paclitaxel versus gemcitabine and paclitaxel in patients with metastatic pancreatic cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Germany Hungary Poland +2

  • Phase II Study of Brentuximab Vedotin with Drug Combination in HIV‑Positive Patients with Advanced‑Stage Classic Hodgkin Lymphoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Phase 1 Study of Terbium (161TB) Zadavotide Guraxetan as Neoadjuvant Treatment in Very High‑Risk Prostate Cancer Patients Eligible for Surgery

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    Germany

powered by